News

Chevron's Recent Options Activity Signals Market Sentiment

Chevron's Recent Options Activity Signals Market Sentiment

Recent Trends in Chevron Options Trading

Investors are increasingly showing a bullish stance on Chevron. Notably, those with significant capital are taking positions that could indicate upcoming price movements for Chevron (CVX).

This insight is critical for retail traders as they navigate the market landscape.

Today, we observed striking trades on publicly available options history, showcasing a notable activity around CVX. The implication is clear: when such significant trades occur, it's often indicative of major players anticipating market movements.

So, how do we decipher the actions of these investors?

Recently, our options scanner uncovered an unusual number of trades for Chevron, totaling 17 distinct transactions.

This is not standard behavior.

The sentiment among these large-scale traders is divided, with 52% exhibiting bullish behaviors and 35% bearish. Out of all the trades analyzed, 5 were puts amounting to $197,606, while 12 were calls, totaling an impressive $686,798.

Anticipated Price Movements for Chevron

By analyzing both Volume and Open Interest related to these contracts, it appears that significant players are targeting a price range for Chevron between $95 and $200 over the past quarter.

Understanding Volume and Open Interest

Monitoring the volume and open interest is a vital practice in options trading. This data provides insights into the liquidity and market interest pertaining to Chevron's options within specific strike prices. In particular, recent trends reflect movement within the $95 to $200 strike price range over the last month for Chevron's trades.

Chevron Call and Put Volume: Last 30 Days

Analyzing the call and put volumes helps traders gain perspective on market dynamics. Keep an eye on the activity for these contracts to make informed decisions.

Key Options Activity

We've identified several noteworthy actions:

1. Symbol: CVX | Type: CALL | Sentiment: NEUTRAL | Exp. Date: 06/18/26 | Total Trade Price: $125.3K | Volume: 20

2. Symbol: CVX | Type: CALL | Sentiment: BEARISH | Exp. Date: 04/04/25 | Total Trade Price: $83.0K | Volume: 207

3. Symbol: CVX | Type: PUT | Sentiment: BULLISH | Exp. Date: 04/17/25 | Total Trade Price: $81.5K | Volume: 60

4. Symbol: CVX | Type: CALL | Sentiment: BULLISH | Exp. Date: 12/18/26 | Total Trade Price: $75.4K | Volume: 13

5. Symbol: CVX | Type: CALL | Sentiment: BULLISH | Exp. Date: 03/21/25 | Total Trade Price: $70.4K | Volume: 664

About Chevron

Chevron stands as a powerful integrated energy corporation with global operations encompassing exploration, production, and refining. As the second-largest oil enterprise in the United States, Chevron boasts a remarkable production rate of 3.1 million barrels of oil equivalent daily. This includes significant contributions from natural gas as well as liquid assets.

Chevron actively engages in production across various continents, ensuring its operations span North America, South America, Europe, Africa, Asia, and Australia. Additionally, they operate several refineries within the U.S. and Asia, collectively handling 1.8 million barrels of oil per day. Its proven reserves at the close of 2023 stood at 11.1 billion barrels of oil equivalent.

After a detailed review of the options activities surrounding Chevron, it's crucial to delve into the company's ongoing performance within the market.

Current Market Position of Chevron

  • Trading volume reported at 3,316,461, with CVX currently priced at $156.28, reflecting a 1.37% increase.
  • RSI indicators signify that Chevron's stock maintains a neutral position, neither overbought nor oversold.
  • Upcoming earnings announcement is anticipated within approximately 70 days.

Perspectives from Analysts on Chevron

In recent weeks, analysts have provided insights into Chevron's stock, with predictions averaging a target price around $174. Analysts from various institutions, including Barclays and Truist Securities, maintain favorable ratings and higher price targets for Chevron.

Active involvement in options trading carries inherent risks and potential rewards. Savvy traders navigate these waters through continuous education, strategy adaptation, and market monitoring. Stay up-to-date with the latest trends in Chevron options trading to enhance your investment decision-making.

Frequently Asked Questions

What does a bullish stance on Chevron options mean?

A bullish stance indicates that investors expect the price of Chevron's stock to rise, leading to more call options being purchased.

How do options traders analyze Chevron?

Traders look at volume and open interest to gauge market interest and liquidity, helping them make informed trading decisions.

What recent price range have investors targeted for Chevron?

Investors have been targeting a price range from $95 to $200 for Chevron's stock primarily over the past quarter.

What is Chevron's current trading volume and stock price?

Chevron's trading volume was reported at 3,316,461, with a stock price of $156.28, reflecting a 1.37% increase.

What are analysts predicting for Chevron's future?

Analysts have set an average target price of around $174 for Chevron, reflecting a generally positive outlook.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 235

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 41

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 147

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 68

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 113

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 22

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 253

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 112

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 0

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
icles